Fresolimumab and Radiotherapy in Metastatic Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Fresolimumab (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 21 Feb 2017 Planned End Date changed from 1 Mar 2016 to 1 Jun 2017.
- 26 Oct 2015 Planned End Date changed from 1 Dec 2015 to 1 Mar 2016, according to ClinicalTrials.gov record.
- 02 Aug 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.